Summary:

- This article discusses the use of a novel therapeutic approach called "oncolytic virotherapy" to treat cancer. Oncolytic viruses are engineered to selectively infect and destroy cancer cells while leaving healthy cells unharmed.

- The researchers developed a new oncolytic virus called "OV-STING" that can activate the body's immune system to recognize and attack cancer cells more effectively. This dual-action approach helps to enhance the cancer-killing effects of the virus.

- Experiments in animal models showed that OV-STING was able to significantly reduce the size of tumors and prolong survival in animals with various types of cancer, including lung, breast, and colon cancer. This suggests the potential for this therapy to be an effective new treatment option for cancer patients.